Identification of benzodiazepine Ro5-3335 as an inhibitor of CBF leukemia through quantitative high throughput screen against RUNX1–CBFβ interaction

Core binding factor (CBF) leukemias, those with translocations or inversions that affect transcription factor genes RUNX1 or CBFB, account for ∼24% of adult acute myeloid leukemia (AML) and 25% of pediatric acute lymphocytic leukemia (ALL). Current treatments for CBF leukemias are associated with si...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Cunningham, Lea, Finckbeiner, Steven, Hyde, R. Katherine, Southall, Noel, Marugan, Juan, Yedavalli, Venkat R. K., Dehdashti, Seameen Jean, Reinhold, William C., Alemu, Lemlem, Zhao, Ling, Yeh, Jing-Ruey Joanna, Sood, Raman, Pommier, Yves, Austin, Christopher P., Jeang, Kuan-Teh, Zheng, Wei, Liu, Paul
Formato: Artigo
Idioma:Inglês
Publicado em: National Academy of Sciences 2012
Assuntos:
Biological Sciences
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3437880/
https://ncbi.nlm.nih.gov/pubmed/22912405
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1200037109
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados